Results 211 to 220 of about 282,999 (266)
Some of the next articles are maybe not open access.
Psychosomatics, 2004
Immunosuppressants are prescribed to prevent rejection of transplanted tissues and organs and are also used in the treatment of autoimmune disorders. Consultation-liaison psychiatrists increasingly encounter patients taking these agents as the number of transplant recipients increases and the indications for the use of immunosuppressants expands. These
Marian, Fireman +3 more
openaire +2 more sources
Immunosuppressants are prescribed to prevent rejection of transplanted tissues and organs and are also used in the treatment of autoimmune disorders. Consultation-liaison psychiatrists increasingly encounter patients taking these agents as the number of transplant recipients increases and the indications for the use of immunosuppressants expands. These
Marian, Fireman +3 more
openaire +2 more sources
Immunosuppression for Myocarditis
New England Journal of Medicine, 1995The diagnosis of acute myocarditis has been a conundrum. One criterion is the clinical picture of the sudden onset of cardiac failure and arrhythmias, often associated with a febrile illness; the other criterion is a myocardial-biopsy specimen that shows a specified degree of myocyte damage and infiltration by T lymphocytes.
W J, McKenna, M J, Davies
openaire +2 more sources
Developments in immunosuppression
Current Opinion in Organ Transplantation, 2020Purpose of review In this review, we discuss achievements in immunosuppression in kidney transplant recipients published at last 18 months. Recent findings Results of recent trials with everolimus in low-risk primary kidney transplant recipients suggest that lowTAC/EVR combination ...
Ondrej, Viklicky +3 more
openaire +2 more sources
Clinical Pharmacology & Therapeutics, 1974
In this paper, I propose to review some of the current concepts of development of immunocompetence, to describe the cellular events that follow exposure to antigen, and to show how these data may be applied to therapy with immunosuppressive drugs. The greatest emphasis will be placed on the glucocorticoids, because these agents are widely employed in ...
openaire +2 more sources
In this paper, I propose to review some of the current concepts of development of immunocompetence, to describe the cellular events that follow exposure to antigen, and to show how these data may be applied to therapy with immunosuppressive drugs. The greatest emphasis will be placed on the glucocorticoids, because these agents are widely employed in ...
openaire +2 more sources
Porokeratosis and immunosuppression
British Journal of Dermatology, 1995Immunosuppression may favour the development of disseminated superficial porokeratosis (DSP). We report the clinical features and the outcome of DSP in 24 patients receiving immunosuppressive treatment (group A), and compare the characteristics of the disease with those of 13 immunocompetent patients with DSP (group B). The two groups were similar with
P L, Bencini +4 more
openaire +2 more sources
Corticosteroids in Immunosuppression
2022Corticosteroids have been utilized as mainstay pharmacological intervention for successful organ transplantation since the beginning. Several challenges exist in establishing a balance between achieving a tolerant atmosphere in the host immune system while minimizing the long-term impact of steroids on the body.
Caroline, Marzbani, Arvind, Bhimaraj
openaire +2 more sources
Principles of Immunosuppression
Critical Care Clinics, 1990One-year graft survival rates of 80% to 90% can now be achieved routinely for primary cadaveric transplants with a variety of CSA-containing regimens. Further improvement of these excellent results may be difficult because large numbers of patients must be evaluated to provide meaningful conclusions.
G L, Chan +3 more
openaire +2 more sources
Clinics in Liver Disease, 2000
The current treatment of posttransplant lymphoproliferative disease (PTLD) includes prophylaxis at the time of transplant, decreasing or stopping immunosuppresion and initiation of antiviral therapy in patients with polymerase chain reaction or clinical evidence of PTLD, and judicial reintroduction of immunosuppression in patients who have cleared ...
D C, Cronin +6 more
openaire +2 more sources
The current treatment of posttransplant lymphoproliferative disease (PTLD) includes prophylaxis at the time of transplant, decreasing or stopping immunosuppresion and initiation of antiviral therapy in patients with polymerase chain reaction or clinical evidence of PTLD, and judicial reintroduction of immunosuppression in patients who have cleared ...
D C, Cronin +6 more
openaire +2 more sources
Biomarkers of Immunosuppression
Critical Care Clinics, 2020It is now recognized that sepsis is not a uniformly proinflammatory state. There is a well-recognized counter anti-inflammatory response that occurs in many patients. The timing and magnitude of this response varies considerably and thus makes its identification and manipulation more difficult.
Abinav K, Misra +2 more
openaire +2 more sources
Transplantation, 2006
Induction immunosuppression is intense, prophylactic therapy used at the time of transplantation based on the empiric observation that more powerful immunosuppression is required to prevent acute rejection early. In the past decade, there has been a growing trend towards the use of specialized agents such as antibody therapies for induction. In general,
openaire +2 more sources
Induction immunosuppression is intense, prophylactic therapy used at the time of transplantation based on the empiric observation that more powerful immunosuppression is required to prevent acute rejection early. In the past decade, there has been a growing trend towards the use of specialized agents such as antibody therapies for induction. In general,
openaire +2 more sources